![GLP-1 Eligibility Requirements: BMI, Comorbidities & Prior Authorization [Template]](http://sybtx0-zn.myshopify.com/cdn/shop/articles/hero_imag_6e950020-98da-44a0-b10a-9d3475d2aeba.jpg?v=1776124726&width=1100)
GLP-1 Eligibility Requirements: BMI, Comorbidities & Prior Authorization [Template]
By Logan GelzerUnderstanding GLP-1 eligibility requirements is the first critical step in your weight management journey. With nearly 100% of GLP-1 prescriptions now requiring prior authorization as of 2025 (compared to only 3-5% in 2020), knowing the specific BMI thresholds, comorbidity documentation, and insurance criteria can save you weeks of delays.
This guide breaks down exactly what you need to qualify for GLP-1 medications in 2026, including the new TrumpRx program and Medicare GLP-1 Bridge policy changes that are reshaping access.
Standard BMI Requirements for GLP-1 Medications
The FDA has established clear BMI thresholds for anti-obesity medication (AOM) approval. These requirements vary based on your health profile and insurance coverage type.
| Eligibility Category | BMI Requirement | Additional Criteria |
|---|---|---|
| Obesity Indication | BMI ≥ 30 kg/m² | Standard FDA requirement for AOMs |
| Overweight + Comorbidity | BMI ≥ 27 kg/m² | Hypertension, Type 2 Diabetes, or Sleep Apnea |
| High-Risk Populations | BMI ≥ 25 kg/m² | Specific ethnic/minority groups |
| Medicaid Coverage | BMI ≥ 35 kg/m² | Varies by state budget constraints |
💡 Key Insight: Patients who research eligibility requirements before their consultation are 3x more likely to receive approval on their first attempt.
Required Comorbidity Documentation
If your BMI falls between 27-30, you'll need documented evidence of weight-related health conditions. Here's what insurers typically require:
Accepted Comorbidities
- Hypertension — Blood pressure readings over 130/80 mmHg on multiple occasions
- Type 2 Diabetes — HbA1c ≥ 6.5% or fasting glucose ≥ 126 mg/dL
- Sleep Apnea — Confirmed via sleep study (polysomnography)
- Dyslipidemia — Elevated LDL or triglycerides despite lifestyle intervention
- Cardiovascular Disease — History of heart attack, stroke, or established CVD
Documentation Timeline
Most insurance companies require comorbidity documentation from within the last 12 months. Some stricter plans may require evidence of failed lifestyle interventions over 6+ months before approving medication.
Prior Authorization: What You Need to Know
As of 2025, nearly 100% of GLP-1 prescriptions require prior authorization (PA), compared to only 3-5% in 2020. This administrative hurdle is the most common reason for treatment delays.
⚠️ Important: Prior authorization approval rates vary significantly by insurance carrier. Commercial plans approve approximately 65-70% of initial requests, while Medicaid plans average 45-50%.
PA Process Timeline
- Provider Submission — Your doctor submits clinical documentation (2-3 business days)
- Insurance Review — Medical team evaluates request (5-10 business days)
- Decision Notification — Approval, denial, or request for additional information (1-3 business days)
- Appeal Process — If denied, you have 180 days to appeal with additional documentation
Special Considerations for 2026 Policy Changes
Several major policy shifts are affecting GLP-1 access this year:
TrumpRx Program (February 2026)
The new federal direct-to-consumer program caps out-of-pocket costs at $350/month for cash-paying patients. However, these payments typically do not count toward insurance deductibles.
Medicare GLP-1 Bridge (July 2026)
Starting July 2026, eligible Part D enrollees can access GLP-1 medications with a $50 copayment cap. Requirements include BMI of 30+ or 27+ with specific comorbidities.
Medicaid BALANCE Model (2026-2027)
State Medicaid programs are rolling out coverage at different rates. As of early 2026, only 13 states cover GLP-1s for obesity treatment due to budget constraints.
Frequently Asked Questions
Who qualifies for GLP-1 medications?
Adults with a BMI of 30 or higher qualify automatically. Those with a BMI of 27-29.9 qualify if they have at least one weight-related comorbidity such as hypertension, type 2 diabetes, or sleep apnea.
What BMI thresholds apply for insurance coverage?
Commercial insurance typically follows FDA guidelines (BMI 30+ or 27+ with comorbidities). Medicaid programs often require BMI 35+ due to budget constraints. Medicare Bridge program requires BMI 30+ or 27+ with comorbidities starting July 2026.
Is prior authorization always required?
As of 2025, nearly 100% of GLP-1 prescriptions require prior authorization. The process typically takes 7-14 business days. Working with a provider experienced in PA submissions can improve approval rates.
Can I appeal a GLP-1 denial?
Yes, you have 180 days to appeal a denial. Successful appeals typically include additional medical documentation, letters of medical necessity, and evidence of failed lifestyle interventions.
How long does GLP-1 approval take?
Initial prior authorization decisions take 7-14 business days on average. Appeals can add an additional 30-45 days. Starting the process with complete documentation reduces delays.
Key Takeaways
GLP-1 eligibility hinges on BMI thresholds, comorbidity documentation, and insurance-specific requirements. With prior authorization now standard, preparation is essential. The 2026 policy landscape offers new pathways through TrumpRx and Medicare programs, but each has distinct eligibility criteria.
Understanding these requirements before your consultation can reduce approval time from months to weeks.
⚕️ Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any medication. Individual eligibility and treatment decisions should be made in consultation with your physician.